Last quarter (Q ), Benitec Biopharma's total revenue was $14.00K, a decrease of -44.00% from the same quarter last year. In Q, Benitec Biopharma's net income was $-5.41M. See Benitec Biopharma’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Jun 22	Jun 21	Jun 20	Jun 16	Jun 12
Total Revenue	$ 62.00K	$ 73.00K	$ 59.00K	$ 97.00K	$ 346.51K	$ 0.00
Cost of Revenue	$ 9.00K	$ 9.00K	$ 123.00K	$ -185.00K	$ 103.80K	$ 120.14K
Gross Profit	$ 39.00K	$ 64.00K	$ -64.00K	$ 282.00K	$ 242.70K	$ -120.14K
Operating Expense	$ 18.44M	$ 17.92M	$ 13.53M	$ 8.56M	$ 16.20M	$ 4.59M
Operating Income	$ -18.39M	$ -17.85M	$ -13.60M	$ -8.28M	$ -15.96M	$ -4.71M
Net Non Operating Interest Income Expense	$ -38.00K	$ -32.00K	$ -6.00K	$ 62.00K	-	$ 160.98K
Other Income Expense	$ -420.00K	$ -322.00K	$ -280.00K	$ -55.00K	$ -2.54M	$ 343.33K
Pretax Income	$ -18.85M	$ -18.21M	$ -13.88M	$ -8.27M	$ -18.50M	$ -4.21M
Tax Provision	-	-	-	-	$ 0.00	$ 0.00
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -18.85M	$ -18.21M	$ -13.88M	$ -8.27M	$ -18.50M	$ -4.21M
Basic EPS	-	-	-	-	-	-
Diluted EPS	-	-	-	-	-	-
Basic Average Shares	-	-	-	-	-	-
Diluted Average Shares	-	-	-	-	-	-
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	$ 373.39K	-
Total Expenses	$ 18.45M	$ 17.93M	$ 13.65M	$ 8.38M	$ 16.31M	-
Net Income From Continuing And Discontinued Operation	$ -18.85M	$ -18.21M	$ -13.88M	$ -8.27M	$ -18.50M	$ -4.21M
Normalized Income	$ -18.45M	$ -17.96M	$ -13.56M	$ -8.19M	$ -15.96M	$ -4.21M
Interest Expense	$ 38.00K	$ 32.00K	-	-	-	$ 10.72K
EBIT	$ -18.81M	$ -18.18M	$ -13.60M	$ -8.28M	$ -15.96M	$ -4.20M
EBITDA	$ -18.43M	$ -17.78M	$ -13.17M	$ -7.91M	$ -15.74M	$ -4.19M

Currency in USD

Benitec Biopharma Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing